 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1532 | 回復: 4 | ||
[求助]
求助，大俠們，幫忙查一下USP35里面的celecoxib，著急啊謝謝
|
| 我的郵箱是zkx0928@126.com，先謝謝啦 |
回復此樓» 猜你喜歡
26考博申請 學or專
已經有15人回復
-
人工智能賦能聚合物及復合材料模型應用與實踐
已經有0人回復
-
藥理學論文潤色/翻譯怎么收費?
已經有202人回復
-
各國和國際組織現行藥典注射用水質量標準
已經有0人回復
-
求助用微譜數據庫查詢
已經有0人回復
-
計算化學與人工智能驅動的MOFs性能預測與篩選技術
已經有0人回復
-
研三實驗求指導
已經有0人回復
-
金屬材料多尺度計算模擬技術與應用：微觀機理到宏觀性能的集成工作
已經有0人回復
-
江西科技師范大學微生物天然藥物老師介紹
已經有23人回復
» 本主題相關價值貼推薦，對您同樣有幫助:
- 求教：博后申請中外國教授發(fā)來email要求發(fā)送些學位文件請大家?guī)兔Υ_認一下
已經有16人回復
- 請高手幫忙翻譯一段話 謝謝了！我英語很爛。。
已經有3人回復
- 高手進來幫幫忙
已經有3人回復
- 幫忙翻譯一下摘要啊
已經有1人回復
- 跪求能用微譜數據庫的蟲子們，幫忙查一下碳譜數據，本人送6個金幣�。。�
已經有7人回復
- 幫忙分析下ASPEN PLUS 11.1中的這個錯誤報告
已經有10人回復
- 用過偏光顯微鏡的大俠請進
已經有7人回復
- 麻煩幫忙翻譯哈下面這句話啊，把它翻譯為英語，謝謝！
已經有6人回復
- 自覺發(fā)熱證，請蟲友們幫忙…
已經有6人回復
- 加一個碳。。。。幫忙一下 謝謝大俠們
已經有5人回復
- 求助SRIM中文教程
已經有3人回復
- 求助：投稿了4個月，今天收到了一封奇怪的郵件。請大俠們幫忙分析一下
已經有16人回復
- 【求助】MS中dmol3模塊——兩種分子的共吸附優(yōu)化
已經有9人回復
- 【求助】申請荷蘭大學的蟲子們進來啊，幫幫忙分析下外導的意思，謝謝哈�。。�！
已經有23人回復
癡夷子皮
版主 (文壇精英)
老痞
- DRDEPI: 8
- 應助: 2016 (講師)
- 貴賓: 5.368
- 金幣: 54487.3
- 散金: 41688
- 紅花: 303
- 沙發(fā): 1206
- 帖子: 32611
- 在線: 4303.7小時
- 蟲號: 674536
- 注冊: 2008-12-14
- 性別: GG
- 專業(yè): 無神論
- 管轄: 人文社科
【答案】應助回帖
★ ★ ★
感謝參與，應助指數 +1
從頭開始: 金幣+3 2012-04-11 11:25:02
感謝參與，應助指數 +1
從頭開始: 金幣+3 2012-04-11 11:25:02
|
Add the following: Celecoxib (sel'' e kox' ib). C17H14F3N3O2S 381.4 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide; p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide [169590-42-5]. DEFINITION Celecoxib contains NLT 98.0% and NMT 102.0% of C17H14F3N3O2S, calculated on the anhydrous basis. IDENTIFICATION • A. Infrared Absorption 197: [Note—Methods 197A, 197K, or 197M under Infrared Absorption may be used. ] [Note—If the spectra obtained show differences, dissolve the substance to be examined and the Reference Standard separately in isopropyl alcohol, evaporate to dryness, and record the new spectra. ] • B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. ASSAY • Procedure Buffer: 2.7 g/L of monobasic potassium phosphate adjusted with phosphoric acid to a pH of 3.0 ± 0.2 Mobile phase: Methanol, acetonitrile, and Buffer (3:1:6) Diluent: Methanol and water (3:1) System suitability solution: 0.5 mg/mL of USP Celecoxib RS and 2.4 µg/mL each of USP Celecoxib Related Compound A RS and USP Celecoxib Related Compound B RS in Diluent Standard solution: 0.5 mg/mL of USP Celecoxib RS in Diluent Sample solution: 0.5 mg/mL of Celecoxib in Diluent Chromatographic system (See Chromatography 621, System Suitability.) Mode: LC Detector: UV 215 nm Column: 4.6-mm × 25-cm; 5-µm packing L11 Column temperature: 60 Flow rate: 1.5 mL/min Injection size: 25 µL Run time: About 1.5 times the celecoxib peak elution System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Relative standard deviation: NMT 0.73%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of C17H14F3N3O2S in the portion of Celecoxib taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response from the Sample solution rS = = peak response from the Standard solution CS = = concentration of the Standard solution (mg/mL) CU = = concentration of the Sample solution (mg/mL) Acceptance criteria: 98.0%–102.0% on the anhydrous basis IMPURITIES Inorganic Impurities • Heavy Metals: NMT 20 ppm Diluent: Acetone and water (17:3) Standard solution: Dilute 1.0 mL of Standard Lead Solution, prepared as directed under Heavy Metals 231, Special Reagents, with Diluent to 20 mL. Sample solution: Dissolve 0.50 g of Celecoxib in 20 mL of Diluent. Blank solution: 20 mL of Diluent Analysis Samples: Standard solution, Blank solution, and Sample solution To each solution, add 2 mL of pH 3.5 Acetate Buffer, prepared as directed under Heavy Metals 231, Method I. Mix, and add to each solution 1.2 mL of thioacetamide–glycerin base TS. Mix immediately, and allow to stand for 2 min. Pass the solutions through a filter of 0.45-µm pore size. Compare the spots on the filters obtained from each of the solutions. Acceptance criteria: The brownish-black color of the spot resulting from the Sample solution is not more intense than that of the spot resulting from the Standard solution. The test is invalid if the Standard solution does not show a brownish-black color compared to the Blank solution. • Residue on Ignition 281: NMT 0.2%, using a platinum crucible Organic Impurities • Procedure Buffer, Mobile phase, Diluent, System suitability solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. Standard solution: 0.5 µg/mL of USP Celecoxib RS in Diluent System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution Signal-to-noise ratio: NLT 20, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of each impurity in the portion of Celecoxib taken: Result = (rU/rS) × (CS/CU) × 100 rU = = peak response for each impurity in the Sample solution rS = = peak response of celecoxib in the Standard solution CS = = concentration of celecoxib in the Standard solution (mg/mL) CU = = concentration of Celecoxib in the Sample solution (mg/mL) Acceptance criteria Individual impurities: See Table 1. [Note—Disregard any impurity peak less than 0.05%. ] SPECIFIC TESTS • Water Determination, Method I 921: NMT 0.5%, using a 400-mg sample ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight containers, protected from light and moisture. Store at room temperature. • USP Reference Standards 11 USP Celecoxib RS p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound A RS 4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 USP Celecoxib Related Compound B RS 4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide. C17H14F3N3O2S 381.4 1S (USP35) Auxiliary Information— Please check for your question in the FAQs before contacting USP. USP35–NF30 Supplement : No. 1 Page 5447 Pharmacopeial Forum: Volume No. 36(6) Page 1519 |
wangyi85
2樓2012-04-10 16:49:16
癡夷子皮
版主 (文壇精英)
老痞
- DRDEPI: 8
- 應助: 2016 (講師)
- 貴賓: 5.368
- 金幣: 54487.3
- 散金: 41688
- 紅花: 303
- 沙發(fā): 1206
- 帖子: 32611
- 在線: 4303.7小時
- 蟲號: 674536
- 注冊: 2008-12-14
- 性別: GG
- 專業(yè): 無神論
- 管轄: 人文社科
3樓2012-04-10 16:51:06
4樓2012-04-11 10:59:10
5樓2012-07-02 10:14:19
相關版塊跳轉
我要訂閱樓主 wangyi85 的主題更新
| 5 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 收08調劑生 +3 | komorebi69 2026-03-18 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 一志愿國科過程所081700，274求調劑 +3 | 三水研0水立方 2026-03-23 | 3/150 |
|
|
[考研] 333求調劑 +3 | ALULU4408 2026-03-23 | 3/150 |
|
|
|
[考研] 一志愿上海交大生物與醫(yī)藥專碩324分，求調劑 +5 | jiajunX 2026-03-22 | 5/250 |
|
|
|
[考研] 350求調劑 +6 | weudhdk 2026-03-19 | 6/300 |
|
|
|
[考研] 306求調劑 +5 | 來好運來來來 2026-03-22 | 5/250 |
|
|
|
[考研] 尋找調劑 +4 | 倔強芒? 2026-03-21 | 4/200 |
|
|
|
[考博] 招收博士1-2人 +3 | QGZDSYS 2026-03-18 | 4/200 |
|
|
|
[基金申請] 山東省面上項目限額評審 +4 | 石瑞0426 2026-03-19 | 4/200 |
|
|
|
[考研] 302求調劑 +12 | 呼呼呼。。。。 2026-03-17 | 12/600 |
|
|
|
[考研] 266求調劑 +3 | 哇呼哼呼哼 2026-03-20 | 3/150 |
|
|
|
[考研] 324分 085600材料化工求調劑 +4 | llllkkkhh 2026-03-18 | 4/200 |
|
|
|
[考研] 294求調劑材料與化工專碩 +15 | 陌の森林 2026-03-18 | 15/750 |
|
|
|
[考研] 考研調劑求學校推薦 +3 | 伯樂29 2026-03-18 | 5/250 |
|
|
|
[考研] 288求調劑 +16 | 于海海海海 2026-03-19 | 16/800 |
|
|
|
[考研] 290求調劑 +7 | ^O^乜 2026-03-19 | 7/350 |
|
|
|
[考研]
 295復試調劑
+8
|
簡木ChuFront 2026-03-19 | 8/400 |
|
|
|
[考研] 材料學求調劑 +4 | Stella_Yao 2026-03-20 | 4/200 |
|
|
|
[考研] 085600材料與化工調劑 324分 +10 | llllkkkhh 2026-03-18 | 12/600 |
|
|
|
[考研] 一志愿福大288有機化學，求調劑 +3 | 小木蟲200408204 2026-03-18 | 3/150 |
|